PlainBillCongress, translated.Legislation. Context. Public interest.Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1903-1904)
Congressional Research Service
Version 00 · Introduced in Senate · Mar 6, 2001
Global Access to AIDS Treatment Act of 2001 - Declares it is U.S. policy that the United States will not seek the revocation or revision of intellectual property or competition laws or policies that regulate pharmaceuticals or medical technologies used to treat HIV/AIDS in any foreign country undergoing an HIV/AIDS-related public health crisis (sub-Saharan Africa and any other country determined by the President to be going through such crisis) if such foreign country's laws or policies: (1) promote access to such pharmaceuticals or technologies for affected populations; and (2) provide intellectual property protection consistent with the Agreement on Trade-Related Aspects of Intellectual Property Rights of the Uruguay Round Agreements Act.Urges the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) to: (1) carry out HIV/AIDS activities in foreign countries that are undergoing an HIV/AIDS-related public health crisis; and (2) lead the international organization of the manufacture and distribution of pharmaceuticals or medical technologies for HIV/AIDS, and the global registration of such products.Amends the Trade Act of 1974 to exempt, with respect to HIV/AIDS pharmaceuticals and medical technologies, any foreign country that is undergoing an HIV/AIDS-related public health crisis, and is implementing laws or policies that regulate pharmaceuticals or medical technologies used to treat HIV/AIDS, from certain provisions declaring that a foreign country may be determined to deny adequate and effective protection of intellectual property rights even though it may be in compliance with the Agreement. Declares that such country shall be construed to provide adequate and effective protection of intellectual property rights if its laws or policies promote access to such pharmaceuticals or technologies for their affected populations or within other countries undergoing an HIV/AIDS-related public health crisis. Directs the President to instruct the United States Trade Representative not to seek the revocation or revision of such laws or policies.Provides for the development and implementation of: (1) simplified and adapted protocols for the delivery of HIV/AIDS treatments in the resource-poor settings of the developing world; (2) programs to strengthen and broaden health care systems infrastructure, and the capacity of health care systems in developing foreign countries to deliver HIV/AIDS pharmaceuticals; and (3) a database of HIV/AIDS pharmaceuticals.Amends the Public Health Service Act to establish the Foreign HIV/AIDS Assistance Loan Repayment Program to encourage physicians and other specified health professionals to provide HIV/AIDS treatment and care in developing foreign countries. Authorizes the Secretary of Health and Human Services to pay or defer up to $5,000 for graduate education loans provided to an individual under such program for each year of the individual's obligated service in providing HIV/AIDS-related services in a developing foreign country.
People & committees
Sen. Feinstein, Dianne [D-CA] · D–CA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S1903-1904)
Sponsor introductory remarks on measure. (CR S1902)
Introduced in Senate
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 19, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze S.463 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine S.463 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine S.463 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine S.463 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.